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013.05.0Abstract Background: Cardiac involvement in systemic sclerosis (SSc) is often clinically occult.
The aim of this study was the evaluation of early subclinical right ventricular (RV) involvement
in patients with limited form of systemic sclerosis by tissue Doppler.
Methods: Twenty female patients with limited cutaneous SSc and 20 control female subjects,
matched for age were studied with transthoracic echocardiography and tissue Doppler imaging
(TDI) to assess RV function. Patients with pulmonary hypertension, chronic renal failure, diabetes
mellitus, hypertension, heart failure, left ventricular hypertrophy, ischemic or rheumatic heart dis-
ease were excluded.
Results: Patients with limited form SSc had signiﬁcant lower tricuspid annulus peak systolic veloc-
ities (ST) (9.95 ± 1.78 vs. 11.05 ± 1.53 cm/s, p < 0.044), early (ET) (9.65 ± 1.30 vs.
12.50 ± 1.23 cm/s, p < 0.0001), late (AT) diastolic velocity (12.60 ± 2.01 vs. 18.15 ± 1.81 cm/s,
p< 0.0001), and tricuspid annular plane systolic excursion (TAPSE) (23.05 ± 3.50 vs.
26.50 ± 1.90, p< 0.001) compared to controls. Myocardial performance index (MPI) of the RV
was higher in SSc patients compared to controls (0.41 ± 0.05 vs. 0.30 ± 0.02, p< 0.0001). There
were signiﬁcant correlations between disease duration and ST and RV MPI (r= 0.883,
p< 0.0001; r= 0.686, p< 0.001, respectively).
Conclusions: Patients with limited form of SSc present with pulsed-tissue Doppler imaging indices
indicative of right ventricle dysfunction, which had signiﬁcant correlations with disease duration.
Tissue Doppler is a valuable non-invasive tool for detecting RV myocardial involvement in patients
with limited SSc.
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021. Introduction
Systemic sclerosis (SSc) is a chronic disease of unknown
etiology, characterized by skin ﬁbrosis, microvascular
abnormalities, and involvement of multiple internal organs.1,2
There are two major disease presentations: (1) diffuse
cutaneous SSc (dcSSc) associated with a high risk of earlygyptian Society of Cardiology.
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ited cutaneous SSc (lcSSc) associated with calcinosis cutis,
Raynaud’s phenomenon, esophageal dysmotility, sclerodactly,
and telangiectasia.3
Diffuse cutaneous SSc (dcSSc) and lcSSc differ in their clin-
ical course, serologic markers and outcome.4 Various patho-
physiological mechanisms were found to contribute to the
pathogenesis of SSc, such as immune system activation, vascu-
lar damage, ﬁbroblast proliferation and collagen over-produc-
tion.5,6 Vascular abnormalities are generally more common in
lcSSc than in dcSSc.4
All epidemiologic studies in SSc have reported that women
outnumber men with female to male ratios usually being 4:1–
6:1.7 The reason for this female preponderance is not well
understood. There is speculation that the difference may be re-
lated to hormones, pregnancy-related events or gender speciﬁc
environmental exposures.8
During the past four decades, death rates owing to SSc-re-
lated complications have gradually decreased, while death
rates due to atherosclerotic cardiovascular disease or cerebro-
vascular disease substantially increased. Currently, cardiovas-
cular related deaths are responsible for a 20–30% mortality
rate in SSc patients, and it may occur in these patients more
than a decade earlier.9
Cardiac involvement is often clinically occult. Cardiac
symptoms are usually delayed and non-speciﬁc, thus often mis-
recognized or underestimated at the time of the diagnosis.10
Cardiac involvement may affect the endocardium, myocar-
dium and pericardium, separately or concomitantly. As a con-
sequence, pericardial effusion, atrial and/or ventricular
arrhythmias, conduction disease, valvular regurgitation, myo-
cardial ischemia11, myocardial hypertrophy and heart failure
have been reported.12
Right ventricular (RV) chamber is often involved in sys-
temic pathologies as a consequence of direct injury extension,
afterload changes or ventricular interdependence which is
mainly due to the close anatomic association between the
two ventricles.13 However, this issue has not been often ex-
plored by non-invasive techniques because of RV complex
geometry which precludes an accurate assessment of RV inter-
nal chamber dimensions and their changes during cardiac
cycle.14
2. Aim of the work
The aim of this study was the evaluation of subclinical right
ventricular involvement in patients with limited form of sys-
temic sclerosis by tissue Doppler.3. Patients and methods
Twenty female patients with limited cutaneous systemic sclero-
sis were enrolled in this study, with a mean age of
39.05 ± 12.77 years. They were collected from the inpatient
clinic of Dermatology, and Andrology department, Mansoura
university hospital from January 2010 until October 2012.
During the study period, we had two male patients with lim-
ited SSc, so we conducted the study on females patients only.
Diagnosis of systemic sclerosis was established according to
the American Rheumatism Associations criteria for the diag-nosis of SSc.15 Patients should have either: (1) Scleroderma
proximal to the digits, affecting limbs, face, neck, or trunk
or (2) At least 2 minor criteria, consisting of: a- Sclerodactyly.
b- Digital pitted scars. c- Bilateral pulmonary ﬁbrosis. Differ-
ential diagnosis between lSSc and dSSc was made according to
the criteria of LeRoy et al.3
The limited cutaneous SSc is deﬁned by skin involvement
conﬁned to the face and extremeties. Anti-nuclear antibodies
can be found and usually organ function remains quite nor-
mal.3 Disease duration was determined from the onset of ﬁrst
symptoms referable to scleroderma.
Raynaud’s phenomena and digital ulcers are diagnosed
clinically. Raynaud’s phenomena severity is based on patient
perception and more accurately by the Raynaud’s condition
score that combines the number and duration of attacks.16
All patients underwent a physical examination (including
skin changes: extent of sclerosis, presence of calcinosis cutis,
ﬁnger ulcers, pitted scars, telangiectasia, Raynaud’s phenom-
ena and musculoskeletal involvement (stiffness, limited range
of movement, pain, swelling), laboratory testing (including a
complete blood picture, blood glucose, stool, urine analysis,
HCV, erythrocyte sedimentation rate (ESR), serum creatinine,
serum bilirubin, alanine transaminase (ALT), antinuclear anti-
body, and anti Scl-70 antibody assessment), chest X-ray, pul-
monary function tests, abdominal ultrasound, endoscopic
examination, barium swallow, ECG, and echocardiography.
Exclusion criteria include patients with chronic renal fail-
ure, diabetes mellitus, pulmonary or arterial hypertension,
heart failure, left ventricular hypertrophy, ischemic or rheu-
matic heart disease, malignancy, pregnancy, and any other sys-
temic disease which could affect the heart.
At the time of the study our patients were receiving drugs
including vasodilator (neﬁdipine), phototherapy, low dose
prednisolone <10 mg/day and H2 receptor antagonists.
3.1. Controls
Twenty control female subjects, matched for age (41.9 ± 8.33
years) were recruited among healthy hospital personnel for
comparison. They were all free of any cardiovascular symp-
toms, and had normal clinical examination, ECG, and chest
radiography. All subject gave their informed consent to be in-
cluded in the study.
The protocol was approved by our ethical committee, and
an informed consent were taken from the patients and
controls.3.2. Echocardiography
Transthoracic Doppler echocardiography was performed with
GE (vivid 3 pro) NORWAY, using 2.5–3.5 MHZ phased array
transducer. Subjects were examined in supine, left-lateral
position. They underwent conventional M-mode and two-
dimensional echocardiography from a left parasternal and api-
cal window. M-mode measurements of the LV diastolic
(LVDD) and systolic (LVSD) diameters, left atrial (LA) diam-
eter, diastolic thickness of the left ventricle posterior wall
(PWT), and interventricular septum (SWT) were obtained.
Ejection fraction (EF) was calculated according to the modi-
ﬁed Simpson’s rule.17
Table 1 Clinical and laboratory data in patients with limited
systemic sclerosis.
Limited systemic sclerosis (n= 20)
Age (years) 39.05 ± 12.77
Disease duration (years) 11.25 ± 5.55
Systolic BP (mmHg) 124.5 ± 14.03
Diastolic BP (mmHg) 78.5 ± 8.12
Raynaud’s phenomena 15 (75%)
Pitted scar 20 (100%)
Esophageal motility disorder 5 (25%)
Joint aﬀection 11 (55%)
Lung ﬁbrosis 0
ESR (mm/h) 35 ± 12
ANA positive 9 (45%)
Anti Scl- 70 antibody 0
Serum creatinine (mg/dl) 0.86 ± 0.048
ALT (U/L) 27.55 ± 2.33
Serum bilirubin (mg/dl) 0.83 ± 0.04
BP = Blood pressure, ESR= Erythrocyte sedimentation rate,
ANA= Antinuclear antibody, ALT = Alanine transaminase.
Table 2 Left ventricular function in patients and control
group.
Limited SSc (n= 20) Control (n= 20) p value
LVSD cm 3.17 ± 0.311 3.22 ± 0.336 NS
LVDD cm 5.12 ± 0.51 5.03 ± 0.25 NS
PWT mm 10.55 ± 1.27 9.35 ± 0.74 0.001
SWT mm 10.60 ± 1.27 8.95 ± 0.82 0.0001
LVEF% 63.25 ± 5.96 64.15 ± 5.07 NS
E m/s 0.78 ± 0.13 0.85 ± 0.17 0.001
A m/s 0.73 ± 0.11 0.63 ± 0. 39 0.001
E/A ratio 1.10 ± 0.14 1.34 ± 0.19 0.01
LVSD= left ventricular end-systolic diameter, LVDD= left ven-
tricular end-diastolic diameter, LVEF= left ventricular ejection
fraction. PWT= posterior wall thickness, SWT= interventricular
septal thickness.
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chamber views, with the sample volume placed at the level of
the mitral valve leaﬂet tips. The following diastolic parameters
were measured: early (E) and late (A) peak mitral inﬂow veloc-
ities, and E/A ratio (E/A).18
Pulmonary artery systolic pressure (PAP) was estimated
from peak tricuspid regurgitation jet velocity by continuous
wave Doppler echocardiogram using the simpliﬁed Bernoulli
equation, and adding the estimated right atrial pressure
(10 mmHg).19 All patients with pulmonary artery systolic pres-
sure P40 mmHg were excluded from the study.
Pulsed wave TDI of the tricuspid annular motion at the lat-
eral free wall was obtained from the apical 4-chamber view
using a pulsed wave Doppler sampling gate of 2–4 mm and a
sweep of 100–150 mm/s. Care was taken to obtain an ultra-
sound beam parallel to the direction of the tricuspid annular
motion. Peak systolic (ST), peak early (ET) and late (AT) dia-
stolic tricuspid annular velocities were obtained. When evalu-
ating peak systolic velocity, the initial peak that occurs
during isometric contraction was ignored. All pulsed Doppler
tissue imaging parameters were measured on three consecutive
heart cycles and the mean value was calculated.20
Tricuspid annular plane systolic excursion (TAPSE), de-
ﬁned as the difference in the displacement of the RV base from
end-diastole to end-systole, was obtained from the apical four-
chamber view, the M-mode cursor was positioned at the junc-
tion of the tricuspid valvular plane with the RV free wall.
TAPSE <16 mm indicates RV systolic dysfunction.20
Myocardial performance index (MPI) of the RV provides
an index of global RV function was calculated by measuring
the isovolumic contraction time (IVCT), isovolumic relaxation
time (IVRT), and ejection time (ET) indices from the pulsed
tissue Doppler velocity of the lateral tricuspid annulus. Myo-
cardial performance index = IVCT+ IVRT/RV ejection time
(ET).20
3.3. Statistical analysis
All data were analyzed using a SPSS software package (version
17.0, SPSS Inc. Chicago, Illinois, USA). Continuous variables
were expressed as mean ± SD, and categorical variables were
expressed as percentage. Comparisons between the patients
and the matched controls were performed using the unpaired
Student’s t test (for normally distributed variables) and
Mann–Whitney U test (for non-normally distributed vari-
ables). Pearson correlation coefﬁcients were used to explore
relationships between the RV MPI, peak ST, and disease dura-
tion. P value of <0.05 was considered statistically signiﬁcant.4. Results
Clinical and laboratory data in patients with limited systemic
sclerosis were shown in Table 1. Twenty female patients, mean
age (39.05 ± 12.77 years), 15 (75%) of the patients had
Raynaud’s manifestation, while all patients had pitted scars,
11 (55%) had joint affection in the form of arthralgia, 5
(25%) had esophageal motility disorder, while none had inter-
stitial lung ﬁbrosis. Serological antibodies analysis detected
anti-nuclear antibody (ANA) in 9 (45%) patients, and none
of them had anti Scl-70 antibody. Erythrocyte sedimentationrate (ESR) was 35 ± 12 mm/h, while serum creatinine, ALT,
and serum bilirubin were normal in all the patients.
The echocardiographic data of left ventricular function are
summarized in Table 2. Patients with limited SSc had
signiﬁcant higher values of transmitral peak A (p < 0.001)
and lower values of peak E (p < 0.001), with consequent
reduction in the E/A ratio (p < 0.01) compared to normal sub-
jects. There was signiﬁcant increase in PWT (p< 0.001) and
SWT (p< 0.0001) in systemic sclerosis patients than in control
group. Left ventricle dimensions and ejection fraction were
comparable between the two groups.
Table 3 represents right ventricular function analysis in lim-
ited systemic sclerosis patients and control group. We found
signiﬁcant lower peak tricuspid annulus systolic velocities
(ST) measured by TDI in scleroderma patients (9.95 ± 1.78
vs. 11.05 ± 1.53 cm/s, p < 0.044), lower tricuspid annulus
early diastolic velocity (ET) in SSc patients (9.65 ± 1.30 vs.
12.50 ± 1.23 cm/s, p < 0.0001), and Tricuspid annulus late
diastolic velocities AT (12.60 ± 2.01 vs. 18.15 ± 1.81 cm/s,
p< 0.0001), while isovolumic relaxation time were markedly
prolonged in SSc patients (35.35 ± 12.74 vs. 19.20 6.25 ms,
Table 3 Right ventricular function in patients and control
group.
Limited SSc (n= 20) Control (n= 20) p value
ST, cm/s 9.95 ± 1.78 11.05 ± 1.53 0.044
ET, cm/s 9.65 ± 1.30 12.50 ± 1.23 0.0001
AT, cm/s 12.60 ± 2.01 18.15 ± 1.81 0.0001
IVRT, ms 35.35 ± 12.74 19.20 ± 6.25 0.0001
RV MPI 0.41 ± 0.05 0.30 ± 0.02 0.001
TAPSE, mm 23.05 ± 3.50 26.50 ± 1.90 0.001
ST = Peak systolic myocardial velocity, ET = Early diastolic
myocardial velocity, AT = Late diastolic myocardial velocity,
IVRT= Isovolumetric relaxation time, RV MPI = Right ventricle
myocardial performance index, TAPSE= Tricuspid annular plane
systolic excursion.
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tients than in controls (0.41 ± 0.05 vs. 0.30 ± 0.02,
p< 0.0001). There was signiﬁcant lower TAPSE in SSc pa-
tients (23.05 ± 3.50 vs. 26.50 ± 1.90, p< 0.001).
Systemic sclerosis disease duration had signiﬁcant negative
correlation with peak tricuspid annulus systolic velocity (ST)
(r= 0.883, p< 0.0001) and signiﬁcant positive correlation
with right ventricular myocardial performance index
(r= 0.686, p< 0.001) (Fig. 1 and 2).
5. Discussion
Cardiac abnormalities could be more prevalent and severe in
the diffuse cutaneous subtype systemic sclerosis, but there is
increasing evidence suggesting that cardiac involvement is also
a frequent ﬁnding in the limited cutaneous subtype.21Figure 1 Scatter plot showing the lateral tricuspid annulusAlthough myocardial ﬁbrosis is a frequent pathological
ﬁnding in patients affected by scleroderma, cardiac involve-
ment can be clinically silent.22 The early identiﬁcation of SSc
patients at higher risk of cardiac and pulmonary impairment,
prior to the development of severe vasculopathy, and right side
heart failure is important to modify the disease process by new
potential therapies.10,23
The aim of our study was to evaluate right ventricular func-
tion by tissue Doppler in asymptomatic female patients with
limited cutaneous systemic sclerosis without pulmonary
hypertension.
In our study there was left ventricular diastolic dysfunction
with normal LV systolic function in patients with SSc as re-
ﬂected by lower mitral peak early diastolic velocity, and E/A
ratio in patients with limited SSc with no difference in left ven-
tricle dimensions and LV ejection fraction. The diastolic
abnormalities in SSc may reﬂect primary myocardial ﬁbrous
tissue deposition. Poanta et al.21 showed signiﬁcant differences
between systemic sclerosis patients and control group for peak
A velocity, E/A ratio, and E/Ea ratio with no difference in LV
systolic function but 75% of their patients had diffuse form of
SSc.21 Maione et al.24 showed LV diastolic dysfunction in SSc
patients.24 Plazak and coworkers 2002, employing tissue
Doppler imaging (TDI) in SSc patients found a discrete inci-
dence of LV diastolic dysfunction and alterations in longitudi-
nal myocardial ﬁbers.25 Mele et al.26 concluded that TDI-
derived strain, strain rate, and E/Ea can detect impairment
of LV myocardial function in asymptomatic patients with
SSc with normal LV ejection fraction better than TDI systolic
velocities.26
The use of tissue Doppler imaging (TDI) for evaluation of
RV function allows for a high recovery rate of sufﬁcient qual-
ity signals27, direct measurements of long axis myocardial tis-
sue velocity changes that are most relevant to RVpeak systolic velocity (ST) in relation to disease duration.
Figure 2 Scatter plot showing the myocardial performance index of the right ventricle in relation to disease duration.
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present study, pulsed-TDI measurements showed an evidence
of RV diastolic dysfunction (lower peak ET and higher peak
AT, Table 3) in the presence of normal pulmonary artery pres-
sures. In a study done by Huez et al.27 tissue Doppler imaging
was performed at rest and during exercise, and they suggested
that patients with systemic sclerosis may present with latent
pulmonary hypertension as a likely cause of right ventricular
diastolic dysfunction.30
The peak RV ST and TAPSE were signiﬁcantly lower com-
pared to the control in this study. The lower peak ST reﬂects
RV intrinsic myocardial dysfunction which had good correla-
tion with MRI derived RVEF, while TAPSE is useful for eval-
uation RV longitudinal function. D’Andrea et al.31 reported
that in SSc, peak systolic RV SR and strain were both reduced
in basal, middle and apical RV lateral free walls, and in basal
and middle LV lateral walls.31
The RV myocardial performance index of our patients was
signiﬁcantly elevated compared to control group, suggesting
higher susceptibility to RV dysfunction in patients with lcSSc.
MPI is considered to be an index of global ventricular func-
tion, including both systolic and diastolic function, with the
advantage of being measured at the same site during the same
cycle using TDI. D’Andrea et al.31 reported that RV MPI was
elevated in 43% of their patients.32
The above results revealed that in patients with lcSSc with-
out pulmonary hypertension, systolic and diastolic RV func-
tion was impaired and those RV dysfunction appear before
any clinical sign or symptom. This could be explained by a
preferential RV sensitivity to the effects of systemic dis-
ease.33,34 In addition, resting measurements may not reﬂect
exercise-induced pulmonary hypertension, which can be prom-
inent during daily activities in systemic sclerosis patients.35,36
Our results of RV dysfunction were in accordance with
Schattke et al.37 but 50% of their patients had dcSSc.37 Meune
et al.38 and Dimitroulas et al.39 reported that patients with SSchad impaired left ventricular and right ventricular diastolic
function, compared to controls but they included patients with
dcSSc in their study.38,39
The RV MPI and peak ST signiﬁcantly correlated with the
recognized disease duration. This could be explained by myo-
cardial involvement results from general vasospastic mecha-
nism. Vasospasm would initially impair perfusion and
function. Myocardial ﬁbrosis is thought to occur after repeated
focal ischemia, resulting from abnormal vasoreactivity, with or
without associated structural vascular disease. Primary myo-
cardial disease and relaxation impairment in SS is the result
of ﬁbrotic lesion. Advanced myocardial ﬁbrosis may lead to
heart failure, but in early stages it can cause only subclinical
systolic and diastolic dysfunction.
5.1. Study limitations
The limitations of this study was the small patients number,
and the lack of assessment of pulmonary artery pressure with
exercise beside the lack of magnetic resonance imaging for
assessment of RV function.
6. Conclusion
In conclusion, female patients with limited form of systemic
sclerosis present with pulsed-tissue Doppler imaging indices
indicative of right ventricle dysfunction, which had signiﬁcant
correlations with disease duration. Tissue Doppler imaging are
valuable non-invasive tool for detecting RV myocardial
involvement in patients with limited form of SSc.
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